RecruitingEarly Phase 1NCT06538311
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
Studying Logopenic progressive aphasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Intervention
- Active rTMS(device)
- Enrollment
- 30 enrolled
- Eligibility
- 40-99 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06538311 on ClinicalTrials.govOther trials for Logopenic progressive aphasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT03887481Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPAJohns Hopkins University
- ACTIVE NOT RECRUITINGNANCT04122001Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's DiseaseJohns Hopkins University